These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3911059)

  • 1. Glycosylation of lipoproteins: chemistry and biological implications.
    Flückiger R
    Monogr Atheroscler; 1985; 13():53-62. PubMed ID: 3911059
    [No Abstract]   [Full Text] [Related]  

  • 2. [Separation of lipoproteins as a function of their apolipoprotein composition. Clinical applications].
    Fruchart JC
    Ann Biol Clin (Paris); 1986; 44(2):116-21. PubMed ID: 3092704
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of tocopherol and apolipoprotein A-I immunoreactivity in rat liver chromatin.
    Panin LE; Polyakov LM; Kolosova NG; Russkikh GS; Poteryaeva ON
    Membr Cell Biol; 1998; 11(5):631-40. PubMed ID: 9672881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE; Barrett PH; Demant T; Parhofer KG
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structure and metabolism of lipoproteins].
    Beucler I; Salmon S; Petit E; Ayrault-Jarrier M; Polonovski J
    Ann Biol Clin (Paris); 1986; 44(5):531-5. PubMed ID: 3544976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of atherosclerosis: concepts derived from studies of lipoprotein metabolism and cell biology.
    Mahley RW
    Clin Invest Med; 1986 Nov; 9(4):304-8. PubMed ID: 3026707
    [No Abstract]   [Full Text] [Related]  

  • 7. [Human apolipoprotein E: polymorphism and binding domain of the receptors].
    Bekaert ED; Ayrault-Jarrier M; Polonovski J
    Biochimie; 1986 May; 68(5):629-37. PubMed ID: 3015256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The important role of apolipoprotein C-III in lipoprotein metabolism].
    Fruchart JC; Duriez P
    C R Seances Soc Biol Fil; 1995; 189(5):889-97. PubMed ID: 8673634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction between genes and diet as a determinant of the plasma levels of cholesterol].
    López Miranda J; Ordovás JM; Pérez Jiménez F
    Med Clin (Barc); 1998 Oct; 111(14):546-51. PubMed ID: 9859082
    [No Abstract]   [Full Text] [Related]  

  • 11. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects of lipoprotein metabolism in familial combined hyperlipidaemia.
    de Graaf J; Stalenhoef AF
    Curr Opin Lipidol; 1998 Jun; 9(3):189-96. PubMed ID: 9645500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B and lipoprotein metabolism.
    Sparks JD; Sparks CE
    Adv Lipid Res; 1985; 21():1-46. PubMed ID: 3895843
    [No Abstract]   [Full Text] [Related]  

  • 14. Inherited disorders of lipid transport.
    Schonfeld G
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):229-57. PubMed ID: 2192872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein function in health and disease: insights from natural mutations.
    Franceschini G
    Eur J Clin Invest; 1996 Sep; 26(9):733-46. PubMed ID: 8889435
    [No Abstract]   [Full Text] [Related]  

  • 16. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
    Mahley RW; Angelin B
    Adv Intern Med; 1984; 29():385-411. PubMed ID: 6369930
    [No Abstract]   [Full Text] [Related]  

  • 17. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structure and metabolism of plasma lipoproteins].
    Polonovski J; Beucler I
    Pathol Biol (Paris); 1983 Apr; 31(4):225-34. PubMed ID: 6346237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Structure, metabolism, functions and plasma changes in high density lipoproteins (HDL)].
    Dewailly P; Sezille G; Jaillard J
    Journ Annu Diabetol Hotel Dieu; 1980 May; ():65-81. PubMed ID: 6995678
    [No Abstract]   [Full Text] [Related]  

  • 20. ApoC-III bound to apoB-containing lipoproteins increase with insulin resistance in Cherokee Indian youth.
    Blackett PR; Blevins KS; Quintana E; Stoddart M; Wang W; Alaupovic P; Lee ET
    Metabolism; 2005 Feb; 54(2):180-7. PubMed ID: 15690311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.